MiddleBrook Pharmaceuticals Reschedules Announcement of its Third Quarter 2007 Financial Results to November 14, 2007
08 11월 2007 - 8:45PM
PR Newswire (US)
GERMANTOWN, Md., Nov. 8 /PRNewswire-FirstCall/ -- MiddleBrook
Pharmaceuticals, Inc. (NASDAQ:MBRK), a pharmaceutical company
focused on developing and commercializing novel anti-infective
products, today announced it has revised the date on which it will
release results for the quarter ended September 30, 2007, to
Wednesday, November 14, 2007, before the market opens. A full text
copy of the release will be disseminated at that time and the
Company's investor conference call will also be rescheduled to
Wednesday, November 14, 2007. In light of MiddleBrook's recent
announcement to raise up to $10 million through its agreement with
Deerfield Management, the Company has decided to postpone the
announcement of its third quarter 2007 financial results until
November 14, 2007. The Company had previously scheduled its third
quarter 2007 financial results and conference call for Friday,
November 9, 2007. Edward M. Rudnic, Ph.D., president and chief
executive officer, will host the Company's conference call to
discuss the results and other corporate developments at 10:30 AM ET
on Wednesday, November 14, 2007. Also participating on the call
will be Robert C. Low, vice president, finance and CFO. The
conference call dial-in numbers have not changed. To participate in
the conference call, dial the appropriate number below shortly
before the 10:30 AM start time and ask for the MiddleBrook
Pharmaceuticals conference call hosted by Dr. Rudnic. The
teleconference dial-in numbers are as follows: Domestic callers
1-800-813-8504 International callers 1-706-643-7752 The conference
call will be broadcast simultaneously and archived on the Company's
web site, http://www.middlebrookpharma.com/. Investors should go to
the web site at least 15 minutes early to register, download, and
install any necessary audio software. A replay of the call will be
available on Wednesday, November 14, 2007, beginning at 12:30 PM ET
and will be accessible until Wednesday, November 21, 2007, at 5:00
PM ET. The replay call-in number is 1-800-642-1687 for domestic
callers and 1-706-645-9291 for international callers. The access
number is 23072308. About MiddleBrook Pharmaceuticals: MiddleBrook
Pharmaceuticals, Inc. (NASDAQ:MBRKNASDAQ:formerlyNASDAQ:Advancis
PharmaceuticalNASDAQ:Corporation) is a pharmaceutical company
focused on the development and commercialization of anti-infective
drug products that fulfill substantial unmet medical needs in the
treatment of infectious disease. The Company is developing a
portfolio of anti-infective drugs based on its novel biological
finding that bacteria exposed to antibiotics in front-loaded
staccato bursts, or "pulses," are killed more efficiently and
effectively than those under standard treatment regimens. Based on
this finding, MiddleBrook has developed a proprietary, once-a-day
pulsatile delivery technology called PULSYS(TM). By examining the
resistance patterns of bacteria and applying its delivery
technologies, MiddleBrook has the potential to redefine infectious
disease therapy and significantly improve drug efficacy, shorten
length of therapy, and reduce drug resistance versus currently
available antibacterial products. For more on MiddleBrook, please
visit http://www.middlebrookpharma.com/. DATASOURCE: MiddleBrook
Pharmaceuticals, Inc. CONTACT: Bob Bannon, Vice President, Investor
Relations & Corporate Communications of MiddleBrook
Pharmaceuticals, Inc., +1-301-944-6710, Web site:
http://www.middlebrookpharma.com/
Copyright
Middlebrook Pharmaceuticals (MM) (NASDAQ:MBRK)
과거 데이터 주식 차트
부터 6월(6) 2024 으로 7월(7) 2024
Middlebrook Pharmaceuticals (MM) (NASDAQ:MBRK)
과거 데이터 주식 차트
부터 7월(7) 2023 으로 7월(7) 2024
Middlebrook Pharmaceuticals (MM) (나스닥)의 실시간 뉴스: 최근 기사 0
More Middlebrook Pharmaceuticals (MM) News Articles